Morgan Stanley
THRD

Morgan Stanley’s Third Harmonic Bio THRD Stock Holding History

Morgan Stanley’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-272,473
Closed -$1.48M – 8369
2025
Q2 		$1.48M Sell
272,473
-46,918
-15% -$234K ﹤0.01% 4893
2025
Q1 		$1.11M Buy
319,391
+157,343
+97% +$763K ﹤0.01% 4954
2024
Q4 		$1.67M Sell
162,048
-493
-0.3% -$6.14K ﹤0.01% 4828
2024
Q3 		$2.2M Buy
162,541
+34,849
+27% +$432K ﹤0.01% 4579
2024
Q2 		$1.66M Sell
127,692
-2,447
-2% -$30.3K ﹤0.01% 4675
2024
Q1 		$1.23M Sell
130,139
-254,763
-66% -$2.48M ﹤0.01% 4855
2023
Q4 		$4.22M Buy
384,902
+278,377
+261% +$2.21M ﹤0.01% 4479
2023
Q3 		$681K Sell
106,525
-26,593
-20% -$163K ﹤0.01% 5009
2023
Q2 		$640K Buy
133,118
+45,927
+53% +$219K ﹤0.01% 5097
2023
Q1 		$359K Buy
87,191
+40,656
+87% +$173K ﹤0.01% 5443
2022
Q4 		$200K Buy
46,535
+39,375
+550% +$659K ﹤0.01% 5672
2022
Q3 		$136K Buy
+7,160
New +$129K ﹤0.01% 5922

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley's THRD Position: Q3 2025 in Review

Morgan Stanley sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 272,473 shares — an estimated $1.48M sold.

Morgan Stanley first reported a position in THRD in Q3 2022 and held it in 12 quarters. The position peaked at $4.22M in Q4 2023. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Morgan Stanley reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Morgan Stanley sold 272,473 Third Harmonic Bio shares in Q3 2025, an estimated $1.48M.
  • Morgan Stanley first reported a position in Third Harmonic Bio in Q3 2022 and held it in 12 quarters.
  • Morgan Stanley's Third Harmonic Bio position peaked at $4.22M in Q4 2023.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.